TY - JOUR
T1 - Endothelial cell-mediated type I collagen gel contraction is regulated by hemin
AU - Liu, X. D.
AU - Skold, M.
AU - Umino, T.
AU - Zhu, Y. K.
AU - Romberger, D. J.
AU - Spurzem, J. R.
AU - Rennard, S. I.
N1 - Funding Information:
Supported by the Larson Endowment, University of Nebraska Medical Center.
PY - 2000
Y1 - 2000
N2 - The contraction of three-dimensional type I collagen gels is regarded as a model of contraction during wound healing and tissue remodeling. Because such a process could contribute to vessel narrowing, we hypothesized that endothelial cells may be able to mediate gel contraction. To demonstrate this, type I collagen was extracted from rat tail tendon and used to prepare collagen gels. Bovine arterial endothelial cells (BAECs) or human pulmonary artery endothelial cells (HPAECs) were then plated on the top of the gels in serum-tree Ham's F- 12 medium or 2% fetal calf serum-endothelium growth medium-2 (FCS-EGM2), respectivety. After 48 hours of attachment, gels were released and floated in 0.2% FCS-Ham's F-12 medium (BAECs) or 2% FCS-EGM2 (HPAECs). Gel size was measured with an image analyzer daily for 5 consecutive days. Gels were then digested with collagenase to quantify DNA and hydroxyproline. BAECs contracted the gels in a time-dependent manner over the 5 days. Contraction was dependent on cell density (gel size was 100% of initial size after 5 days with no cells vs 66.4% ± 0.5% with 0.9 x 104 cells/cm2 and 22.1% ± 0.3% with 7.5 x 104 cells/cm2) and was inversely related to collagen concentration (gel size was 22.3% ± 0.05%, 46.4% ± 0.9%, 72.3% ± 0.4%, and 87.4% ± 0.3% of initial size for gels prepared with 0.5 mg/mL, 0.75 mg/mL, 1 mg/mL, and 2 mg/mL of collagen, respectively). Heroin (a precursor for CO) and cytochalasin D inhibited collagen gel contraction mediated by both bovine and human endothelial cells without changing cell number or hydroxyproline content. In contrast, prostaglandin E2, an inhibitor, and transforming growth factor-β1, a stimulator of fibroblast-mediated gel contraction, had no effect on endothelial cell-mediated contraction. These findings demonstrate that endothelial cells are able to contract native type I collagen gels and that this process can be modulated by exogenous mediators. Such a capability may cause remodeling of subjacent matrix of endothelial cells and may contribute to vessel narrowing.
AB - The contraction of three-dimensional type I collagen gels is regarded as a model of contraction during wound healing and tissue remodeling. Because such a process could contribute to vessel narrowing, we hypothesized that endothelial cells may be able to mediate gel contraction. To demonstrate this, type I collagen was extracted from rat tail tendon and used to prepare collagen gels. Bovine arterial endothelial cells (BAECs) or human pulmonary artery endothelial cells (HPAECs) were then plated on the top of the gels in serum-tree Ham's F- 12 medium or 2% fetal calf serum-endothelium growth medium-2 (FCS-EGM2), respectivety. After 48 hours of attachment, gels were released and floated in 0.2% FCS-Ham's F-12 medium (BAECs) or 2% FCS-EGM2 (HPAECs). Gel size was measured with an image analyzer daily for 5 consecutive days. Gels were then digested with collagenase to quantify DNA and hydroxyproline. BAECs contracted the gels in a time-dependent manner over the 5 days. Contraction was dependent on cell density (gel size was 100% of initial size after 5 days with no cells vs 66.4% ± 0.5% with 0.9 x 104 cells/cm2 and 22.1% ± 0.3% with 7.5 x 104 cells/cm2) and was inversely related to collagen concentration (gel size was 22.3% ± 0.05%, 46.4% ± 0.9%, 72.3% ± 0.4%, and 87.4% ± 0.3% of initial size for gels prepared with 0.5 mg/mL, 0.75 mg/mL, 1 mg/mL, and 2 mg/mL of collagen, respectively). Heroin (a precursor for CO) and cytochalasin D inhibited collagen gel contraction mediated by both bovine and human endothelial cells without changing cell number or hydroxyproline content. In contrast, prostaglandin E2, an inhibitor, and transforming growth factor-β1, a stimulator of fibroblast-mediated gel contraction, had no effect on endothelial cell-mediated contraction. These findings demonstrate that endothelial cells are able to contract native type I collagen gels and that this process can be modulated by exogenous mediators. Such a capability may cause remodeling of subjacent matrix of endothelial cells and may contribute to vessel narrowing.
UR - http://www.scopus.com/inward/record.url?scp=0033801207&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033801207&partnerID=8YFLogxK
U2 - 10.1067/mlc.2000.108153
DO - 10.1067/mlc.2000.108153
M3 - Article
C2 - 10945238
AN - SCOPUS:0033801207
SN - 0022-2143
VL - 136
SP - 100
EP - 109
JO - Journal of Laboratory and Clinical Medicine
JF - Journal of Laboratory and Clinical Medicine
IS - 2
ER -